所有图片(3)
About This Item
经验公式（希尔记法）:
C7H8BrN
CAS号:
分子量:
186.05
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22
推荐产品
品質等級
化驗
97%
形狀
solid
mp
38-42 °C
SMILES 字串
Cc1cccc(CBr)n1
InChI
1S/C7H8BrN/c1-6-3-2-4-7(5-8)9-6/h2-4H,5H2,1H3
InChI 密鑰
WJFDCFHWFHCLIW-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
訊號詞
Danger
危險分類
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
其他客户在看
Yi-Shan Li et al.
Talanta, 218, 121143-121143 (2020-08-17)
Dipeptidyl peptidase 4 (DPP-4) inhibitors are incretin-based medications used as oral antidiabetic agents for the treatment of type 2 diabetes. However, DPP-4 inhibitors produce side effects like acute pancreatitis, upper respiratory tract infection, nasopharyngitis, urinary tract infection, serious allergies, cardiovascular
Ying-Jung Wu et al.
Analytical and bioanalytical chemistry, 410(28), 7405-7414 (2018-09-08)
In the clinic, ethosuximide is commonly used to treat generalized absence seizures but has recently been repurposed for other diseases. Because of adverse effects and drug interactions, high-throughput therapeutic drug monitoring of ethosuximide is necessary. Microextraction is a simple, effective
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门